In this review, we delve into BsAbs in B-NHL from the preclinical development to clinical data in both refractory and frontline settings, and then discuss future perspectives.
Imprimis Pharmaceuticals has announced the release of data from a peer-reviewed study of patients receiving Tri-Moxi-Vanc Dropless Therapy (triamcinolone acetonide...
Alcon, unveils new data showing significantly improved near and intermediate distance vision with the AcrySof IQ PanOptix intraocular lens (IOL)...
Kidney injury is frequently seen in patients with end‐stage liver disease from cirrhosis and liver failure. Among selected patients, simultaneous liver kidney (SLK) transplantation provides improved post‐transplant graft and patient outcomes compared to liver transplantation (LT) alone.
To establish standard therapy for patients with advanced-stage low grade B-cell lymphoma.
Six-month results from the BIOLUX P-I study, demonstrating excellent safety and efficacy results for the Biotronik Passeo-18 Lux Paclitaxel Releasing...
For the relief of dry tickly coughs
Merck Inc., announced distant metastasis-free survival (DMFS) results from the Phase III KEYNOTE-716 trial investigating Keytruda, Merck’s anti-PD-1 therapy, versus placebo as adjuvant therapy for patients with resected stage IIB or IIC melanoma.